[Funding News] EvolutionaryScale Secures $142 Mn Funding to Advance Tech in Biology

EvolutionaryScale, a firm specializing in artificial intelligence applied to biology, announced on Tuesday that it successfully secured $142 million in early funding. The funding round was led by Nat Friedman, Daniel Gross, and Lux Capital.

EvolutionaryScale will allocate its investment towards the training of advanced AI models and the expansion of a team to collaborate with the biotech industry.

Amazon Web Services (AWS) and NVIDIA's venture capital arm also contributed to the fundraising efforts.

Read also - Cleantech Solar Raises Rs 855 Cr Funding from Aseem Infrastructure Finance

EvolutionaryScale plans to use its AI for many purposes, including as speeding up the process of finding new drugs and designing microorganisms that can degrade plastic in the environment.

The utilization of artificial intelligence to design novel biological systems is presently a highly captivating field.

EvolutionaryScale is introducing a series of models called ESM3. The smaller ESM3 model is being released as open source for non-commercial research purposes, while AWS and NVIDIA will offer the models for commercial use, including the biggest ESM3 model.

Advertisment

About EvolutionaryScale

Founded in 2023 by Alexander Rives, EvolutionaryScale aims to enhance scientific comprehension of biology for the betterment of human health and society through the development of artificial intelligence.

Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:

Startup Success Stories: Discover inspiring tales of startups overcoming challenges and achieving success.

Funding Startup News: Stay updated with the latest news and trends in startup funding and investment.

Startup Insights: Dive into in-depth analyses of various industries and market trends to make informed business decisions.